
Receptor de Bombesina
Os receptores de bombesina são um grupo de GPCRs ativados por peptídeos semelhantes à bombesina, que estão envolvidos na regulação da função gastrointestinal, do equilíbrio energético e da proliferação celular. Esses receptores são de particular interesse na pesquisa do câncer, pois são frequentemente superexpressos em certos tipos de tumores. Antagonistas de receptores de bombesina são estudados por seu potencial como terapêuticos contra o câncer. Na CymitQuimica, oferecemos uma seleção de moduladores de receptores de bombesina de alta qualidade para apoiar sua pesquisa em oncologia, fisiologia gastrointestinal e sinalização de receptores.
Foram encontrados 37 produtos para "Receptor de Bombesina".
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
CD80-IN-3
CAS:CD80-IN-3 is a potent CD80 inhibitor and inhibits CD80/CD28 interaction (Kd: 125 nM; EC50: 630 nM).Fórmula:C17H10FN3O3Pureza:99.51%Cor e Forma:SolidPeso molecular:323.28Ref: TM-T10722
1mg75,00€5mg177,00€1mL*10mM (DMSO)195,00€10mg289,00€25mg467,00€50mg647,00€100mg802,00€(D-Arg1,D-Pro2,D-Trp7,9,L-Leu11)-Substance P acetate
CAS:(D-Arg1,D-Pro2,D-Trp7,9,L-Leu11)-Substance P (acetate), an antagonist for Substance P and Bombesin, modulates ocular inflammatory responses triggered byFórmula:C77H108N20O13·xC2H4O2Bombesin
CAS:Bombesin: 14-amino acid peptide from toad skin with two mammalian homologs, neuromedin B and gastrin-releasing peptide.Fórmula:C71H110N24O18SCor e Forma:SolidPeso molecular:1619.85RC-3095
CAS:RC-3095, a selective GRPR antagonist, has been shown to have anti-inflammatory properties in different models of inflammation.Fórmula:C56H79N15O9Pureza:98%Cor e Forma:SolidPeso molecular:1106.32BA 1
CAS:Potent BB1, BB2, and BB3 agonist; IC50: 0.26, 1.55, 2.52 nM. Boosts glucose transport in myocytes, promotes cancer cell growth in vitro.Fórmula:C57H76N14O11Pureza:98%Cor e Forma:SolidPeso molecular:1133.32PSMA/GRPR ligand 1
PSMA/GRPR ligand 1 (compound 3) is a bispecific ligand with dual targeting capabilities for tumors that express PSMA(+) and GRPR(+).Cor e Forma:Odour Solid[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P
CAS:Broad-spectrum inverse agonist; potent at ghrelin receptor (EC50=5.2 nM); blocks other neuropeptide receptors; induces apoptosis; inhibits tumor growth.Fórmula:C79H109N19O12Pureza:98%Cor e Forma:SolidPeso molecular:1516.85[D-Phe12]-Bombesin
CAS:Bombesin receptor antagonistFórmula:C74H112N22O18SPureza:98%Cor e Forma:SolidPeso molecular:1629.88[D-Phe12,Leu14]-Bombesin
CAS:Bombesin receptor blocker; stops binding in rat brain (IC50=2 μM), hinders amylase release (IC50=4 μM), reduces appetite suppression in vivo.Fórmula:C77H113F3N22O20Pureza:98%Cor e Forma:SolidPeso molecular:1724.9AMTG-DA1
AMTG-DA1 is a ligand for the gastrin-releasing peptide receptor (GRPR), and it can be utilized in cancer research.Fórmula:C101H149IN22O25Cor e Forma:SolidPeso molecular:2197.0109(D-Phe6,Leu-NHEt13,des-Met14)-Bombesin (6-14)
CAS:(D-Phe6,Leu-NHEt13,des-Met14)-Bombesin (6-14), a bombesin (BBN) antagonist, holds potential for cancer research applications [1].Fórmula:C49H69N13O9Cor e Forma:SolidPeso molecular:984.15BA 1 TFA
BA1 TFA agonizes BB receptors; binds BRS3, GRPR, NMBR with IC50s of 6, 0.4, 2.5 nM.Fórmula:C59H77F3N14O13Cor e Forma:SolidPeso molecular:1247.32Ici 216140
CAS:ICI 216140: GRP/bombesin receptor 2 blocker, potent at 2 nM. Reduces amylase at 2 mg/kg and lowers bombesin-induced blood pressure at 1 mM in rats.Fórmula:C45H65N13O8Cor e Forma:SolidPeso molecular:916.08Biotin-Gastrin Releasing Peptide, human TFA
Biotin-Gastrin Releasing Peptide, human TFA, is a biotinylated form of the gastrin-releasing peptide (GRP). GRP is a neuropeptide known for its growth-stimulating and tumorigenic properties.Cor e Forma:Odour SolidNOTA-P2-RM26
CAS:NOTA-P2-RM26 is a high-affinity NOTA-conjugated bombesin antagonist designed for GRPR-targeted tumor imaging.Fórmula:C73H110N18O19Cor e Forma:SolidPeso molecular:1543.76Gastrin-Releasing Peptide, human
CAS:Gastrin-releasing peptide, released by vagal fibers, stimulates stomach G cells to secrete gastrin, affecting acid secretion and gut motility.Fórmula:C130H204N38O31S2Pureza:98%Cor e Forma:SolidPeso molecular:2859.38GRP (14-27) (human, porcine, canine)
CAS:GRP (14-27) (human, porcine, canine) functions as a ligand for bombesin receptors, with its specific binding being inhibited by GTP and GDP, while GMP does notFórmula:C75H110N24O16S2Pureza:98%Cor e Forma:SolidPeso molecular:1667.96GB-6
CAS:GB-6, a short linear peptide that selectively binds to the gastrin releasing peptide receptor (GRPR), shows potential as a high-contrast imaging probe due toFórmula:C32H45N11O8Pureza:98%Cor e Forma:SolidPeso molecular:711.77RC-3095 TFA
CAS:RC-3095 TFA (RC-3095 (TFA)) is a bombesin/gastrin-releasing peptide (BN/GRP) antagonist with potential anticancer activity.Fórmula:C58H80F3N15O11Pureza:98%Cor e Forma:SolidPeso molecular:1220.34[D-Cys6,Asn7,D-Ala11,Cys14]-Bombesin (6-14)
CAS:[D-Cys6,Asn7,D-Ala11,Cys14]-Bombesin (6-14) is a synthetic peptide that functions as a non-selective bombesin receptor agonist. It exhibits pEC50 values of 8.06 for neuromedin B-preferential bombesin receptor (BB1), 8.69 for gastrin-releasing peptide-preferential bombesin receptor (BB2), and 6.71 for the orphan receptor (BB3). This compound is utilized in studies related to bombesin receptor-associated conditions, including cancer and neurological disorders.Fórmula:C44H64N14O10S2Peso molecular:1013.2

